Integrins are extracellular matrix receptors involved in tumour invasion and angiogenesis.
Although there is evidence that inhibiting integrins might enhance the efficiency of …

Glioblastoma (GBM) is the most aggressive brain cancer and its relapse after surgery, chemo
and radiotherapy appears to be led by GBM stem cells (GSCs). Also, tumor networking and …

Glioblastoma multiforme (GBM) is the most dramatic primary brain cancer with a very poor
prognosis because of inevitable disease recurrence. The median overall survival is less than …

The presence of hypoxic areas in glioblastoma is an important determinant in tumor response
to therapy and, in particular, to radiotherapy. Here we have explored the involvement of …

Simple Summary Glioblastoma stem cells (GBMSCs), which are particularly radio-resistant
and invasive, are responsible for the high recurrence of glioblastoma (GBM). Therefore, there …

FGF2 signaling in glioblastoma induces resistance to radiotherapy, so targeting FGF2/FGFR
pathways might offer a rational strategy for tumor radiosensitization. To investigate this …

Despite maximally safe resection of the magnetic resonance imaging (MRI)–defined contrast-enhanced
(CE) central tumor area and chemoradiotherapy, most patients with …

Hypoxia is a crucial factor in tumor aggressiveness and resistance to treatment, particularly
in glioma. Our previous results have shown that inhibiting the small GTPase RhoB increased …

Radiotherapy is the cornerstone of glioblastoma (GBM) standard treatment. However,
radioresistance of cancer cells leads to an inevitable recurrence. In the present study, we showed …

Farnesylated Ras oncoprotein induces a cellular resistance to ionizing radiation that can be
reversed by farnesyltransferase inhibitors (FTI). We previously demonstrated that, …